<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38958890</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>The Interplay of HIV and Long COVID in Sub-Saharan Africa: Mechanisms of Endothelial Dysfunction.</ArticleTitle><Pagination><StartPage>859</StartPage><EndPage>871</EndPage><MedlinePgn>859-871</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-024-02087-6</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Long COVID affects approximately 5&#xa0;million people in Africa. This disease is characterized by persistent symptoms or new onset of symptoms after an acute SARS-CoV-2 infection. Specifically, the most common symptoms include a range of cardiovascular problems such as chest pain, orthostatic intolerance, tachycardia, syncope, and uncontrolled hypertension. Importantly, these conditions appear to have endothelial dysfunction as the common denominator, which is often due to impaired nitric oxide (NO) mechanisms. This review discusses the role of mechanisms contributing to endothelial dysfunction in Long COVID, particularly in people living with HIV.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Recent studies have reported that increased inflammation and oxidative stress, frequently observed in Long COVID, may contribute to NO dysfunction, ultimately leading to decreased vascular reactivity. These mechanisms have also been reported in people living with HIV. In regions like Africa, where HIV infection is still a major public health challenge with a prevalence of approximately 26&#xa0;million people in 2022. Specifically, endothelial dysfunction has been reported as a major mechanism that appears to contribute to cardiovascular diseases and the intersection with Long COVID mechanisms is of particular concern. Further, it is well established that this population is more likely to develop Long COVID following infection with SARS-CoV-2. Therefore, concomitant infection with SARS-CoV-2 may lead to accelerated cardiovascular disease. We outline the details of the worsening health problems caused by Long COVID, which exacerbate pre-existing conditions such as endothelial dysfunction. The overlapping mechanisms of HIV and SARS-CoV-2, particularly the prolonged inflammatory response and chronic hypoxia, may increase susceptibility to Long COVID. Addressing these overlapping health issues is critical as it provides clinical entry points for interventions that could improve and enhance outcomes and quality of life for those affected by both HIV and Long COVID in the region.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chikopela</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Human Physiology, Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwesigwa</LastName><ForeName>Naome</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37332-0615, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masenga</LastName><ForeName>Sepiso K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>HAND Research Group, School of Medicine and Health Sciences, Mulungushi University, Livingstone Campus, Livingstone, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirabo</LastName><ForeName>Annet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37332-0615, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibao</LastName><ForeName>Cyndya A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37332-0615, USA. cyndya.shibao@vumc.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AHA 967054</GrantID><Agency>American Heart Association</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004730" MajorTopicYN="Y">Endothelium, Vascular</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017954" MajorTopicYN="N" Type="Geographic">Africa South of the Sahara</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">Endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">Immune response</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>6</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38958890</ArticleId><ArticleId IdType="doi">10.1007/s11886-024-02087-6</ArticleId><ArticleId IdType="pii">10.1007/s11886-024-02087-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation. Post COVID-19 condition (Long COVID) 2022 [cited 2024 28-02-2024]. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition .</Citation></Reference><Reference><Citation>Health, NIf. Excellence C. COVID 19 Rapid Guideline. NICE; 2021.</Citation></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk factors for delayed return to Usual Health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;8. https://doi.org/10.15585/mmwr.mm6930e1 . Epub 2020/07/31.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId><ArticleId IdType="pmc">7392393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyasulu PS, Tamuzi JL, Erasmus RT. Burden, causation, and particularities of long COVID in African populations: a rapid systematic review. IJID Reg. 2023;8:137&#x2013;44. https://doi.org/10.1016/j.ijregi.2023.08.004 . Epub 2023/09/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2023.08.004</ArticleId><ArticleId IdType="pubmed">37674565</ArticleId><ArticleId IdType="pmc">10477483</ArticleId></ArticleIdList></Reference><Reference><Citation>*Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O et al. &#x2018;Long COVID&#x2019;: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC infectious diseases. 2021;21(1):304. Epub 2021/03/27. doi: 10.1186/s12879-020-05716-x. PubMed PMID: 33765941; PubMed Central PMCID: PMCPMC7993075. In Africa, patients who recovered from COVID-19 disease may still experience COVID-19 like symptoms, and careful monitoring should be in place after discharge to help mitigate the effects of these symptoms and improve the quality of life of COVID-19 survivors.</Citation></Reference><Reference><Citation>Zulu JE, Banda D, Hines JZ, Luchembe M, Sivile S, Siwingwa M, et al. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study. Pan Afr Med J. 2022. https://doi.org/10.11604/pamj.2022.41.26.30721 . 41:26. Epub 2022/03/17.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2022.41.26.30721</ArticleId><ArticleId IdType="pubmed">36159029</ArticleId><ArticleId IdType="pmc">9474929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long-coronavirus disease among people living with HIV in western India: an observational study. Immun Inflamm Dis. 2021;9(3):1037&#x2013;43. https://doi.org/10.1002/iid3.467 . Epub 2021/06/03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.467</ArticleId><ArticleId IdType="pubmed">34078004</ArticleId><ArticleId IdType="pmc">8239760</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Antar AAR, AIDS. Long COVID in people living with HIV. Current opinion in HIV and. 2023;18(3):126&#x2009;&#x2013;&#x2009;34. Epub 2023/05/05. doi: 10.1097/coh.0000000000000789. PubMed PMID: 37144614; PubMed Central PMCID: PMCPMC10167544.</Citation></Reference><Reference><Citation>Kamanzi P, Mulundu G, Mutale K, Mumba C, Ngalamika O. HIV and inflammatory markers are associated with persistent COVID-19 symptoms. Immun Inflamm Dis. 2023;11(5):e859. https://doi.org/10.1002/iid3.859 . Epub 2023/05/30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.859</ArticleId><ArticleId IdType="pubmed">37249281</ArticleId><ArticleId IdType="pmc">10165949</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G et al. Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID. medRxiv: the preprint server for health sciences. 2022. Epub 2022/07/29. doi: 10.1101/2022.06.21.22276660. PubMed PMID: 35898346; PubMed Central PMCID: PMCPMC9327632.</Citation></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2023;128:102&#x2013;11. PubMed PMID: 36587841; PubMed Central PMCID: PMCPMC9800016.</Citation></Reference><Reference><Citation>Trinh NT, J&#xf6;dicke AM, Catal&#xe0; M, Mercad&#xe9;-Besora N, Hayati S, Lupattelli A, et al. Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. Lancet Respiratory Med. 2024;12(5):e33&#x2013;4. https://doi.org/10.1016/s2213-2600(24)00082-1 . Epub 2024/04/14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(24)00082-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Nemati M, Shahisavandi M, Nemati H, Karimi A, Jafari A, et al. How does COVID-19 vaccination affect long-COVID symptoms? PLoS ONE. 2024;19(2):e0296680. https://doi.org/10.1371/journal.pone.0296680 . Epub 2024/02/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0296680</ArticleId><ArticleId IdType="pubmed">38324547</ArticleId><ArticleId IdType="pmc">10849259</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern Med. 2023;183(6):554&#x2009;&#x2013;&#x2009;64. Epub 2023/03/24. https://doi.org/10.1001/jamainternmed.2023.0743 . PubMed PMID: 36951829; PubMed Central PMCID: PMCPMC10037200 from Gilead Sciences and Tonix Pharmaceuticals and consulting (uncompensated) for Pfizer.</Citation></Reference><Reference><Citation>Zhang B, Thacker D, Zhou T, Zhang D, Lei Y, Chen J et al. Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Project. medRxiv: the preprint server for health sciences. 2024. Epub 2024/05/27. doi: 10.1101/2024.05.14.24307380. PubMed PMID: 38798448; PubMed Central PMCID: PMCPMC11118642.</Citation></Reference><Reference><Citation>Mellor MM, Bast AC, Jones NR, Roberts NW, Ordonez-Mena JM, Reith AJM, Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS (, London et al. England). 2021;35(4):F1-F10. Epub 2021/02/16. doi: 10.1097/QAD.0000000000002836. PubMed PMID: 33587448; PubMed Central PMCID: PMCPMC7924978.</Citation></Reference><Reference><Citation>Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, et al. Characteristics, comorbidities, and outcomes in a Multicenter Registry of patients with Human Immunodeficiency Virus and Coronavirus Disease 2019. Clin Infect Dis. 2021;73(7):e1964&#x2013;72. https://doi.org/10.1093/cid/ciaa1339 . Epub 2020/09/10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1339</ArticleId><ArticleId IdType="pubmed">32905581</ArticleId></ArticleIdList></Reference><Reference><Citation>Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases SA. Risk factors for Coronavirus Disease 2019 (COVID-19) death in a Population Cohort Study from the Western Cape Province, South Africa. Clin Infect Dis. 2021;73(7):e2005&#x2013;15. https://doi.org/10.1093/cid/ciaa1198 . Epub 2020/08/30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1198</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto P, Nagu T, et al. Minimizing the impact of the triple burden of COVID-19, Tuberculosis and HIV on health services in sub-saharan Africa. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2021;113(Suppl 1):S16&#x2013;21. PubMed PMID: 33757874; PubMed Central PMCID: PMCPMC7980520.</Citation></Reference><Reference><Citation>Heidary M, Asadi A, Noorbakhsh N, Dashtbin S, Asadollahi P, Dranbandi A, et al. COVID-19 in HIV-positive patients: a systematic review of case reports and case series. J Clin Lab Anal. 2022;36(4):e24308. https://doi.org/10.1002/jcla.24308 . Epub 2022/02/22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24308</ArticleId><ArticleId IdType="pubmed">35187723</ArticleId><ArticleId IdType="pmc">8993621</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO. HIV and AIDS key facts 2023 [cited 2024 21/03/2024]. https://www.who.int/news-room/fact-sheets/detail/hiv-aids .</Citation></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC, Pathophysiology. Transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782&#x2013;93. https://doi.org/10.1001/jama.2020.12839 . Epub 2020/07/11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zulli A, Burrell LM, Buxton BF, Hare DL. ACE2 and AT4R are present in diseased human blood vessels. Eur J Histochem. 2008;52(1):39&#x2013;44. Epub 2008/05/27. doi: 10.4081/1184. PubMed PMID: 18502721.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/1184</ArticleId><ArticleId IdType="pubmed">18502721</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3&#x2013;20. https://doi.org/10.1038/s41580-021-00418-x . Epub 2021/10/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka I, Bertram S, M&#xfc;ller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122&#x2013;34. https://doi.org/10.1128/jvi.02232-10 . Epub 2011/02/18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02232-10</ArticleId><ArticleId IdType="pubmed">21325420</ArticleId><ArticleId IdType="pmc">3126222</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L, Benigni A, Remuzzi G. SARS-CoV-2 and the spike protein in endotheliopathy. Trends Microbiol. 2024;32(1):53&#x2013;67. https://doi.org/10.1016/j.tim.2023.06.004 . Epub 2023/07/02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2023.06.004</ArticleId><ArticleId IdType="pubmed">37393180</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel EB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905&#x2013;19. https://doi.org/10.1007/s10096-020-04138-6 . Epub 2021/01/04.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId><ArticleId IdType="pmc">7778857</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenith T, Martin H, Le Breuilly M, Whitehouse T, Gao-Smith F, Duggal N, et al. High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep. 2022;12(1):10484. https://doi.org/10.1038/s41598-022-13825-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13825-7</ArticleId><ArticleId IdType="pubmed">35729319</ArticleId><ArticleId IdType="pmc">9212205</ArticleId></ArticleIdList></Reference><Reference><Citation>Montiel V, Lobysheva I, Gerard L, Vermeersch M, Perez-Morga D, Castelein T, et al. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine. 2022;77:103893. https://doi.org/10.1016/j.ebiom.2022.103893 . Epub 2022/02/27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103893</ArticleId><ArticleId IdType="pubmed">35219085</ArticleId><ArticleId IdType="pmc">8865837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd Zawawi Z, Kalyanasundram J, Mohd Zain R, Thayan R, Basri DF, Yap WB. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-&#x3b1;) in COVID-19: Prognosis, Therapeutic and Management. International journal of molecular sciences. 2023;24(7). Epub 2023/04/14. https://doi.org/10.3390/ijms24076142 . PubMed PMID: 37047115; PubMed Central PMCID: PMCPMC10094668.</Citation></Reference><Reference><Citation>Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72(8):4410&#x2013;5. https://doi.org/10.1128/IAI.72.8.4410-4415.2004 . Epub 2004/07/24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.72.8.4410-4415.2004</ArticleId><ArticleId IdType="pubmed">15271897</ArticleId><ArticleId IdType="pmc">470699</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Sharif K, O&#x2019;Regan A, Bridgewood C. The role of cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020;19(6):102537. https://doi.org/10.1016/j.autrev.2020.102537 . Epub 2020/04/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId><ArticleId IdType="pmc">7195002</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. https://doi.org/10.1186/s12985-022-01814-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId><ArticleId IdType="pmc">9134144</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang X, Li Y, Huang JA, Jiang J, Su N. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Virol J. 2021;18(1):117. https://doi.org/10.1186/s12985-021-01588-y . Epub 2021/06/06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01588-y</ArticleId><ArticleId IdType="pubmed">34088317</ArticleId><ArticleId IdType="pmc">8177255</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Lin J, Zhao Y, Ma X, Yi H. Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses. J Zhejiang Univ Sci B. 2021;22(8):609&#x2013;32. https://doi.org/10.1631/jzus.B2000808 . Epub 2021/08/21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1631/jzus.B2000808</ArticleId><ArticleId IdType="pubmed">34414698</ArticleId><ArticleId IdType="pmc">8377577</ArticleId></ArticleIdList></Reference><Reference><Citation>Aluri J, Cooper MA, Schuettpelz LG. Toll-Like Receptor Signaling in the Establishment and Function of the Immune System. Cells. 2021;10(6). Epub 2021/07/03. https://doi.org/10.3390/cells10061374 . PubMed PMID: 34199501; PubMed Central PMCID: PMCPMC8228919.</Citation></Reference><Reference><Citation>Kigerl KA, de Rivero Vaccari JP, Dietrich WD, Popovich PG, Keane RW. Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014;258:5&#x2013;16. https://doi.org/10.1016/j.expneurol.2014.01.001 . Epub 2014/07/16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2014.01.001</ArticleId><ArticleId IdType="pubmed">25017883</ArticleId><ArticleId IdType="pmc">4974939</ArticleId></ArticleIdList></Reference><Reference><Citation>de Rivero Vaccari JP, Dietrich WD, Keane RW. Therapeutics targeting the inflammasome after central nervous system injury. Transl Res. 2016;167(1):35&#x2013;45. https://doi.org/10.1016/j.trsl.2015.05.003 . Epub 2015/05/31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2015.05.003</ArticleId><ArticleId IdType="pubmed">26024799</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman WR, de Rivero Vaccari JP, Locovei S, Qiu F, Carlsson SK, Scemes E, et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J Biol Chem. 2009;284(27):18143&#x2013;51. https://doi.org/10.1074/jbc.M109.004804 . Epub 2009/05/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.004804</ArticleId><ArticleId IdType="pubmed">19416975</ArticleId><ArticleId IdType="pmc">2709345</ArticleId></ArticleIdList></Reference><Reference><Citation>Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397&#x2013;411. https://doi.org/10.1038/nri3452 . Epub 2013/05/25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3452</ArticleId><ArticleId IdType="pubmed">23702978</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Sharma A. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed. J Chemother. 2008;20(6):672&#x2013;83. https://doi.org/10.1179/joc.2008.20.6 . Epub 2009/01/09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/joc.2008.20.6</ArticleId><ArticleId IdType="pubmed">19129063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol. 2010;125(5):985&#x2013;92. https://doi.org/10.1016/j.jaci.2010.01.058 . Epub 2010/04/16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2010.01.058</ArticleId><ArticleId IdType="pubmed">20392481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: a double Edged Sword. Front Immunol. 2021;12:742941. https://doi.org/10.3389/fimmu.2021.742941 . Epub 2021/10/19.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742941</ArticleId><ArticleId IdType="pubmed">34659238</ArticleId><ArticleId IdType="pmc">8515020</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R et al. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm. Vaccines. 2021;9(5). Epub 2021/05/06. https://doi.org/10.3390/vaccines9050436 . PubMed PMID: 33946736; PubMed Central PMCID: PMCPMC8145892.</Citation></Reference><Reference><Citation>Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, et al. Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: a consecutive case series. EBioMedicine. 2021;67:103355. https://doi.org/10.1016/j.ebiom.2021.103355 . Epub 2021/04/30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103355</ArticleId><ArticleId IdType="pubmed">33915337</ArticleId><ArticleId IdType="pmc">8072072</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2023;76(3):e487&#x2013;90. Epub 2022/09/03. https://doi.org/10.1093/cid/ciac722 . PubMed PMID: 36052466; PubMed Central PMCID: PMCPMC10169416.</Citation></Reference><Reference><Citation>**Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, Monsalve DM, Zhu C, Li QZ et al. Autoimmunity is a hallmark of post-COVID syndrome. Journal of translational medicine. 2022;20(1):129. Epub 2022/03/18. https://doi.org/10.1186/s12967-022-03328-4 . PubMed PMID: 35296346; PubMed Central PMCID: PMCPMC8924736. This study highlights that people living with HIV and recovering from SARS-CoV-2 infection may be at higher risk of Long COVID.</Citation></Reference><Reference><Citation>Albornoz EA, Amarilla AA, Modhiran N, Parker S, Li XX, Wijesundara DK, et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol Psychiatry. 2023;28(7):2878&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara PC, Macias-Verde D, Burgos-Burgos J. Age-induced NLRP3 inflammasome over-activation increases lethality of SARS-CoV-2 Pneumonia in Elderly patients. Aging Dis. 2020;11(4):756&#x2013;62. https://doi.org/10.14336/AD.2020.0601 . Epub 2020/08/09.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2020.0601</ArticleId><ArticleId IdType="pubmed">32765942</ArticleId><ArticleId IdType="pmc">7390513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol. 2010;10(7):514&#x2013;26. https://doi.org/10.1038/nri2802 . Epub 2010/06/26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2802</ArticleId><ArticleId IdType="pubmed">20577268</ArticleId><ArticleId IdType="pmc">3899649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gary F. In: Goldman Lee SA, editor. 47 - mechanisms of inflammation and tissue repair. Goldman&#x2019;s Cecil Medicine: Saunders; 2012. pp. 230&#x2013;5.</Citation></Reference><Reference><Citation>Yoshizumi M, Perrella MA, Burnett JC Jr., Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73(1):205&#x2013;9. https://doi.org/10.1161/01.res.73.1.205 . Epub 1993/07/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.res.73.1.205</ArticleId><ArticleId IdType="pubmed">7685252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A, Black S, Catravas J. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc Pharmacol. 2008;49:134&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2008.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundd P, Pospieszalska M, Cheung L, Konstantopoulos K, Ley K. Biomechanics of leukocyte rolling. Biorheology. 2011;48(1):1&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/BIR-2011-0579</ArticleId><ArticleId IdType="pubmed">21515934</ArticleId><ArticleId IdType="pmc">3103268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, Yao Q, Chen C. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest. 2002;82:245&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.3780418</ArticleId><ArticleId IdType="pubmed">11896203</ArticleId></ArticleIdList></Reference><Reference><Citation>De Caterina R, Libby P. Endothelial Dysfunctions and Vascular Disease: Blackwell Publishing; 2007.</Citation></Reference><Reference><Citation>Lubos E, Diane E, Handy, Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Bioscience: J Virtual Libr. 2008;1(13):5323&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/3084</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham FD, Erlemann KR, Gravel S, Rokach J, Powell WS. Oxidative stress-induced changes in pyridine nucleotides and chemoattractant 5-lipoxygenase products in aging neutrophils. Free Radic Biol Med. 2009;47(1):62&#x2013;71. https://doi.org/10.1016/j.freeradbiomed.2009.04.016 . Epub 2009/04/21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.04.016</ArticleId><ArticleId IdType="pubmed">19376220</ArticleId><ArticleId IdType="pmc">2891157</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau SB, Carneiro FS, Tostes RC. Differential modulation of nitric oxide synthases in aging: therapeutic opportunities. Front Physiol. 2012;3:218. https://doi.org/10.3389/fphys.2012.00218 . Epub 2012/06/28.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00218</ArticleId><ArticleId IdType="pubmed">22737132</ArticleId><ArticleId IdType="pmc">3382417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo M, Scialo F, Cacciapuoti S, Pinchera B, De Rosa A, Cernera G, et al. Inducible nitric oxide synthase (iNOS): why a different production in COVID-19 patients of the two waves? Viruses. 2022;14(3). https://doi.org/10.3390/v14030534 . PubMed PMID: 35336941; PubMed Central PMCID: PMCPMC8948744. Epub 2022/03/27.</Citation></Reference><Reference><Citation>Sugiura H, Ichinose M. Nitrative stress in inflammatory lung diseases. Nitric Oxide. 2011;25(2):138&#x2013;44. https://doi.org/10.1016/j.niox.2011.03.079 . Epub 2011/03/29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2011.03.079</ArticleId><ArticleId IdType="pubmed">21440655</ArticleId></ArticleIdList></Reference><Reference><Citation>Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23(2):75&#x2013;93. PubMed PMID: 20438856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.niox.2010.04.007</ArticleId><ArticleId IdType="pubmed">20438856</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcados GE, Muhammad A, Oladipo OO, Makama S, Meseko CA. Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants. Front Cell Infect Microbiol. 2021;11:654813. https://doi.org/10.3389/fcimb.2021.654813 . Epub 2021/06/15.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.654813</ArticleId><ArticleId IdType="pubmed">34123871</ArticleId><ArticleId IdType="pmc">8188981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cafaro A, Barillari G, Moretti S, Palladino C, Tripiciano A, Falchi M, et al. HIV-1 Tat protein enters dysfunctional endothelial cells via Integrins and renders them permissive to Virus Replication. Int J Mol Sci. 2020;22(1). https://doi.org/10.3390/ijms22010317 . PubMed PMID: 33396807; PubMed Central PMCID: PMCPMC7796023. Epub 2021/01/06.</Citation></Reference><Reference><Citation>Huie RE, Padmaja S. The reaction rate of nitric oxide with superoxide. Free Rad Res Commun. 1993;18:195&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715769309145868</ArticleId></ArticleIdList></Reference><Reference><Citation>Fugen A. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004;75(6):639&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2003.10.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov. 2007;6(8):662&#x2013;80. https://doi.org/10.1038/nrd2222 . Epub 2007/08/02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2222</ArticleId><ArticleId IdType="pubmed">17667957</ArticleId></ArticleIdList></Reference><Reference><Citation>Donia A, Bokhari H. Apoptosis induced by SARS-CoV-2: can we target it? Apoptosis: an international journal on programmed cell death. 2021;26(1&#x2013;2):7&#x2013;8. Epub 2021/01/30. https://doi.org/10.1007/s10495-021-01656-2 . PubMed PMID: 33512610; PubMed Central PMCID: PMCPMC7844099.</Citation></Reference><Reference><Citation>Denicola A, Souza JM, Radi R. Diffusion of peroxynitrite across erythrocyte membranes. Proc Natl Acad Sci USA. 1998;95:3566&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.7.3566</ArticleId><ArticleId IdType="pubmed">9520406</ArticleId><ArticleId IdType="pmc">19876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihm MJ, Jing L, Bauer JA. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol. 2000:182&#x2013;7.</Citation></Reference><Reference><Citation>Ashutosh Kumar S-HC, Maria B, Kadiiska J-S, Hong J, Zielonka B, Kalyanaraman, Ronald P. Mason. Inducible nitric oxide synthase is key to peroxynitrite-mediated, LPS-induced protein radical formation in murine microglial BV2 cells. Free Radic Biol Med. 2014:51&#x2013;9.</Citation></Reference><Reference><Citation>Kline ER, Kleinhenz DJ, Liang B, Dikalov S, Guidot DM, Hart MC, et al. Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am J Physiol - Heart Circ Physiol. 2008;294(6):2792&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.91447.2007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickhout JG, Hossain GS, Pozza LM, Zhou J, Lhotak S, Austin RC. Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis. Arterioscler Thromb Vasc Biol. 2005;25:2623&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000189159.96900.d9</ArticleId><ArticleId IdType="pubmed">16210571</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerstrom S, Gunalan V, Keng CT, Tan YJ, Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology. 2009;395(1):1&#x2013;9. https://doi.org/10.1016/j.virol.2009.09.007 . Epub 2009/10/06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.09.007</ArticleId><ArticleId IdType="pubmed">19800091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631&#x2013;7. https://doi.org/10.1002/path.1570 . Epub 2004/05/14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId><ArticleId IdType="pmc">7167720</ArticleId></ArticleIdList></Reference><Reference><Citation>Avogaro A, de Kreutzenberg SV, Fadini G. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;82(Suppl 2):S94&#x2013;101. https://doi.org/10.1016/j.diabres.2008.09.021 . PubMed PMID: 18954919. Epub 2008/10/29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2008.09.021</ArticleId><ArticleId IdType="pubmed">18954919</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22(supp B):B72&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0828-282X(06)70990-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J. 1996;10(2):283&#x2013;92. https://doi.org/10.1096/fasebj.10.2.8641561 . Epub 1996/02/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.10.2.8641561</ArticleId><ArticleId IdType="pubmed">8641561</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick N, Gimbrone MA Jr. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 1995;9(10):874&#x2013;82. https://doi.org/10.1096/fasebj.9.10.7615157 . Epub 1995/07/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.9.10.7615157</ArticleId><ArticleId IdType="pubmed">7615157</ArticleId></ArticleIdList></Reference><Reference><Citation>Avogaro A, de Kreutzenberg SV, Fadini G. Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract. 2008;82(2):94&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2008.09.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Widlansky ME, Gokce N, Keaney JF Jr., Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149-60. Epub 2003/10/03. https://doi.org/10.1016/s0735-1097(03)00994-x . PubMed PMID: 14522472.</Citation></Reference><Reference><Citation>Ullah W, Saeed R, Sarwar U, Patel R, Fischman DL. COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case Rep. 2020. Epub 2020/04/22. https://doi.org/10.1016/j.jaccas.2020.04.008 . PubMed PMID: 32313884; PubMed Central PMCID: PMCPMC7164919.</Citation></Reference><Reference><Citation>Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA, da Silva LFF, de Oliveira EP, Saldiva PHN, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost. 2020;18(6):1517&#x2013;9. https://doi.org/10.1111/jth.14844 . Epub 2020/04/16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14844</ArticleId><ArticleId IdType="pubmed">32294295</ArticleId><ArticleId IdType="pmc">7262093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Dhawan S, Aggarwal BB. Emodin (3-methyl-1, 6, 8-trihydroxyanthraquinone) inhibits TNF-induced NF-&#x3ba;B activation, I&#x3ba;B degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene. 1998;17(7):913&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1201998</ArticleId><ArticleId IdType="pubmed">9780008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168&#x2009;&#x2013;&#x2009;75. Epub 2003/02/18. https://doi.org/10.1161/01.atv.0000051384.43104.fc . PubMed PMID: 12588755.</Citation></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;. https://doi.org/10.1016/j.cell.2020.02.052 . 80 e8. Epub 2020/03/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId><ArticleId IdType="pmc">7102627</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratchford SM, Stickford JL, Province VM, Stute N, Augenreich MA, Koontz LK, et al. Vascular alterations among young adults with SARS-CoV-2. Am J Physiol Heart Circ Physiol. 2021;320(1):H404&#x2013;10. PubMed PMID: 33306450; PubMed Central PMCID: PMCPMC8083172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00897.2020</ArticleId><ArticleId IdType="pubmed">33306450</ArticleId></ArticleIdList></Reference><Reference><Citation>Szeghy RE, Province VM, Stute NL, Augenreich MA, Koontz LK, Stickford JL, et al. Carotid stiffness, intima-media thickness and aortic augmentation index among adults with SARS-CoV-2. Exp Physiol. 2022;107(7):694&#x2013;707. https://doi.org/10.1113/EP089481 . Epub 2021/04/28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089481</ArticleId><ArticleId IdType="pubmed">33904234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieman S, Melenovsky V, Kass D. Review mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;45(5):932&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000160548.78317.29</ArticleId></ArticleIdList></Reference><Reference><Citation>Najeeb A, Shirwany, Ming-hui Z. Arterial stiffness: a brief review. Acta Pharmacol Sin. 2010;31(10):1267&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2010.123</ArticleId></ArticleIdList></Reference><Reference><Citation>**Chikopela T, Goma F, Kaluba L, Mutale W, Guure C, Heimburger DC et al. Arterial stiffness is associated with oxidative stress and endothelial activation among persons with treated HIV in Zambia. Southern African journal of HIV medicine. 2021;22(1):1298. Epub 2021/12/04. https://doi.org/10.4102/sajhivmed.v22i1 .1298. PubMed PMID: 34858654; PubMed Central PMCID: PMCPMC8603157. In this study, people living with HIV in sub-Saharan Africa had significantly greater oxidative stress and endothelial activation compared to HIV-negative individuals.</Citation></Reference><Reference><Citation>Lemogoum D, Ngatchou W, Borne P. Cardiometabolic phenotype and arterial stiffness in HIV-positive black African patients. OJPM. 2014;4:182&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/ojpm.2014.44024</ArticleId></ArticleIdList></Reference><Reference><Citation>Siedner M, Kim J, Nakku R, Hemphill LTV, Haberer JE. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016;30(4):667&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0000000000000992</ArticleId><ArticleId IdType="pubmed">26636926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaluba L, Goma F, Guure C, Munsaka S, Mutale W, Heimburger DC, et al. Immune activation and arterial stiffness in lean adults with HIV on antiretroviral therapy. South Afr J HIV Med. 2021;22(1):1190. https://doi.org/10.4102/sajhivmed.v22i1.1190 . Epub 2021/04/08.</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/sajhivmed.v22i1.1190</ArticleId><ArticleId IdType="pubmed">33824734</ArticleId><ArticleId IdType="pmc">8008040</ArticleId></ArticleIdList></Reference><Reference><Citation>Margaritis M. Endothelial dysfunction in HIV infection: experimental and clinical evidence on the role of oxidative stress. Annals Res Hosp. 2019;3.</Citation></Reference><Reference><Citation>Feigofsky S, Fedorowski A. Defining Cardiac Dysautonomia - different types, overlap syndromes; case-based presentations. J Atr Fibrillation. 2020;13(1):2403. https://doi.org/10.4022/jafib.2403 . Epub 2020/10/08.</Citation><ArticleIdList><ArticleId IdType="doi">10.4022/jafib.2403</ArticleId><ArticleId IdType="pubmed">33024503</ArticleId><ArticleId IdType="pmc">7533131</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, et al. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists. J Clin Investig. 2020;130(7):3345&#x2013;7. https://doi.org/10.1172/JCI139642 . Epub 2020/05/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139642</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId><ArticleId IdType="pmc">7324164</ArticleId></ArticleIdList></Reference><Reference><Citation>Staedtke V, Bai R-Y, Kim K, Darvas M, Davila ML, Riggins GJ, et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 2018;564(7735):273&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0774-y</ArticleId><ArticleId IdType="pubmed">30542164</ArticleId><ArticleId IdType="pmc">6512810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fudim M, Qadri YJ, Ghadimi K, MacLeod DB, Molinger J, Piccini JP, et al. Implications for Neuromodulation Therapy to Control Inflammation and related Organ Dysfunction in COVID-19. J Cardiovasc Transl Res. 2020;13(6):894&#x2013;9. https://doi.org/10.1007/s12265-020-10031-6 . Epub 2020/05/28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-020-10031-6</ArticleId><ArticleId IdType="pubmed">32458400</ArticleId><ArticleId IdType="pmc">7250255</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopman FA, Chavan SS, Miljko S, Grazio S, Sokolovic S, Schuurman PR, et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci U S A. 2016;113(29):8284&#x2013;9. https://doi.org/10.1073/pnas.1605635113 . Epub 2016/07/07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605635113</ArticleId><ArticleId IdType="pubmed">27382171</ArticleId><ArticleId IdType="pmc">4961187</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaz B, Sinniger V, Hoffmann D, Claren&#xe7;on D, Mathieu N, Dantzer C, et al. Chronic vagus nerve stimulation in Crohn&#x2019;s disease: a 6-month follow&#x2010;up pilot study. Neurogastroenterology Motil. 2016;28(6):948&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12792</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JM, Fuchs RM, Gardner JD, Lazartigues E, Yue X. Nicotine and the renin-angiotensin system. Am J Physiology-Regulatory Integr Comp Physiol. 2018;315(5):R895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00099.2018</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari MF, Raizada MK, Fior-Chadi DR. Nicotine modulates the renin-angiotensin system of cultured neurons and glial cells from cardiovascular brain areas of Wistar Kyoto and spontaneously hypertensive rats. J Mol Neurosci. 2007;33(3):284&#x2009;&#x2013;&#x2009;93. Epub 2007/10/24. https://doi.org/10.1007/s12031-007-9006-x . PubMed PMID: 17952638.</Citation></Reference><Reference><Citation>Ferrari MF, Raizada MK, Fior-Chadi DR. Differential regulation of the renin-angiotensin system by nicotine in WKY and SHR glia. J Mol Neurosci. 2008;35(2):151&#x2013;60. https://doi.org/10.1007/s12031-007-9025-7 . Epub 2008/03/29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-007-9025-7</ArticleId><ArticleId IdType="pubmed">18369742</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vallee A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11(1):14042. https://doi.org/10.1038/s41598-021-93546-5 . Epub 2021/07/09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId><ArticleId IdType="pmc">8263555</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-haul post&#x2013;COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. Case Rep. 2021;3(4):573&#x2013;80.</Citation></Reference><Reference><Citation>Stahlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. Post-COVID-19 Tachycardia Syndrome: a distinct phenotype of Post-acute COVID-19 syndrome. Am J Med. 2021;134(12):1451&#x2013;6. PubMed PMID: 34390682; PubMed Central PMCID: PMCPMC8356730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId><ArticleId IdType="pmc">8356730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19(11):1880&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId><ArticleId IdType="pmc">9287587</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021&#x2013;104. https://doi.org/10.1093/eurheartj/ehy339 . Epub 2018/08/31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy339</ArticleId><ArticleId IdType="pubmed">30165516</ArticleId></ArticleIdList></Reference><Reference><Citation>Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883&#x2013;948. https://doi.org/10.1093/eurheartj/ehy037 . Epub 2018/03/22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy037</ArticleId><ArticleId IdType="pubmed">29562304</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan J, Biaggioni I, Kotsis V, Nilsson P, Grassi G, Fedorowski A, et al. Consensus statement on the definition of orthostatic hypertension endorsed by the American Autonomic Society and the Japanese society of hypertension. Hypertens Res. 2023;46(2):291&#x2013;4. https://doi.org/10.1038/s41440-022-01074-0 . Epub 2022/11/24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01074-0</ArticleId><ArticleId IdType="pubmed">36418529</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodhi HA, Peri-Okonny PA, Schesing K, Phelps K, Ngo C, Evans H, et al. Usefulness of blood pressure variability indices derived from 24-Hour ambulatory blood pressure monitoring in detecting autonomic failure. J Am Heart Association. 2019;8(7):e010161. https://doi.org/10.1161/JAHA.118.010161 . Epub 2019/03/25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.118.010161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow DC, Wood R, Choi J, Grandinetti A, Gerschenson M, Sriratanaviriyakul N, et al. Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia. HIV Clin Trials. 2011;12(3):141&#x2013;50. https://doi.org/10.1310/hct1203-141 . Epub 2011/06/21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1310/hct1203-141</ArticleId><ArticleId IdType="pubmed">21684854</ArticleId><ArticleId IdType="pmc">3175027</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownley KA, Milanovich JR, Motivala SJ, Schneiderman N, Fillion L, Graves JA, et al. Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology. Clin Auton Res. 2001;11(5):319&#x2013;26. Epub 2002/01/05. doi: 10.1007/BF02332978. PubMed PMID: 11758799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02332978</ArticleId><ArticleId IdType="pubmed">11758799</ArticleId></ArticleIdList></Reference><Reference><Citation>Nzuobontane D, Ngu BK, Christopher K. Cardiovascular autonomic dysfunction in africans infected with human immunodeficiency virus. J R Soc Med. 2002;95(9):445&#x2013;7. Epub 2002/09/03. doi: 10.1177/014107680209500905. PubMed PMID: 12205208; PubMed Central PMCID: PMCPMC1279990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014107680209500905</ArticleId><ArticleId IdType="pubmed">12205208</ArticleId><ArticleId IdType="pmc">1279990</ArticleId></ArticleIdList></Reference><Reference><Citation>Eshak N, Abdelnabi M, Ball S, Elgwairi E, Creed K, Test V, et al. Dysautonomia: an overlooked neurological manifestation in a critically ill COVID-19 patient. Am J Med Sci. 2020;360(4):427&#x2013;9. https://doi.org/10.1016/j.amjms.2020.07.022 . Epub 2020/08/03.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2020.07.022</ArticleId><ArticleId IdType="pubmed">32739039</ArticleId><ArticleId IdType="pmc">7366085</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal CM, Wig N, Mishra S, Deepak KK. Heart rate variability in human immunodeficiency virus-positive individuals. Int J Cardiol. 2004;94(1):1&#x2013;6. https://doi.org/10.1016/j.ijcard.2003.02 . Epub 2004/03/05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2003.02</ArticleId><ArticleId IdType="pubmed">14996467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow D, Nakamoto B, So E, Parikh N, Souza S, Kallianpur K, et al. Rates of autonomic dysfunction in HIV patients receiving antiretroviral therapy. J Neurovirol. 2013;19(5):511&#x2013;2. https://doi.org/10.1007/s13365-013-0198-2 . Epub 2013/09/11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-013-0198-2</ArticleId><ArticleId IdType="pubmed">24018903</ArticleId><ArticleId IdType="pmc">4314100</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves AJ, Braga MVA, Santana PH, Resende L, da Silva VJD, Correia D. Linear and non-linear analysis of heart rate variability in HIV-positive patients on two different antiretroviral therapy regimens. BMC Infect Dis. 2021;21(1):1022. https://doi.org/10.1186/s12879-021-06648-w . Epub 2021/10/01.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06648-w</ArticleId><ArticleId IdType="pubmed">34587909</ArticleId><ArticleId IdType="pmc">8482565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: clinical presentation, aetiology and management. J Intern Med. 2019;285(4):352&#x2013;66. https://doi.org/10.1111/joim.12852 . Epub 2018/10/30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828. PubMed PMID: 34144933; PubMed Central PMCID: PMCPMC8455420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId><ArticleId IdType="pmc">8455420</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson-Papp J, Astha V, Nmashie A, Sharma SK, Kim-Schulze S, Murray J, Brain, Behavior, et al. Immun - Health. 2020;7:100112. https://doi.org/10.1016/j.bbih.2020.100112 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100112</ArticleId></ArticleIdList></Reference><Reference><Citation>Tillman TS, Chen Q, Bondarenko V, Coleman JA, Xu Y, Tang P. SARS-CoV-2 spike protein downregulates cell surface &#x3b1;7nAChR through a helical motif in the spike neck. ACS Chem Neurosci. 2023;14(4):689&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.2c00610</ArticleId><ArticleId IdType="pubmed">36745901</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander Y, Osto E, Schmidt-Trucksass A, Shechter M, Trifunovic D, Duncker DJ, et al. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular diseases, coronary Pathophysiology and Microcirculation, and thrombosis. Cardiovascular Res. 2021;117(1):29&#x2013;42. https://doi.org/10.1093/cvr/cvaa085 . Epub 2020/04/14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamboa A, Figueroa R, Paranjape SY, Farley G, Diedrich A, Biaggioni I. Autonomic blockade reverses endothelial dysfunction in obesity-Associated Hypertension. Hypertension. 2016;68(4):1004&#x2013;10. https://doi.org/10.1161/HYPERTENSIONAHA.116.07681 . Epub 2016/08/17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.116.07681</ArticleId><ArticleId IdType="pubmed">27528067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopoorian AH, Wahba A, Celedonio J, Nwazue V, Smith EC, Garland EM, et al. Impaired endothelial function in patients with postural Tachycardia Syndrome. Hypertension. 2021;77(3):1001&#x2013;9. https://doi.org/10.1161/HYPERTENSIONAHA.120.16238 . Epub 2021/01/26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.16238</ArticleId><ArticleId IdType="pubmed">33486983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballester LY, Cap&#xf3;-V&#xe9;lez CM, Garc&#xed;a-Beltr&#xe1;n WF, Ramos FM, V&#xe1;zquez-Rosa E, R&#xed;os R, et al. Up-regulation of the neuronal nicotinic receptor &#x3b1;7 by HIV glycoprotein 120. J Biol Chem. 2012;287(5):3079&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.262543</ArticleId><ArticleId IdType="pubmed">22084248</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques KC, Quaresma JAS, Falc&#xe3;o LFM. Cardiovascular autonomic dysfunction in long COVID: pathophysiology, heart rate variability, and inflammatory markers. Front Cardiovasc Med. 2023;10. https://doi.org/10.3389/fcvm.2023.1256512 .</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>